A PSMA scan is a nuclear medicine imaging technique used in the diagnosis and staging of prostate cancer. It is carried out by injection of a radiopharmaceutical...
20 KB (1,816 words) - 13:54, 16 May 2024
the United States. The FDA considers 68Ga PSMA-11 to be a first-in-class medication. Gallium PSMA scanning is recommended primarily in cases of biochemical...
35 KB (3,520 words) - 00:09, 27 August 2024
(worst prognosis). The extent of cancer spread is assessed by MRI or PSMA scan – a positron emission tomography (PET) imaging technique where a radioactive...
76 KB (8,857 words) - 08:48, 12 August 2024
Gallium (68Ga) gozetotide (redirect from Gallium 68 PSMA-11)
PSMA-11 sold under the brand name Illuccix among others, is a radiopharmaceutical made of 68Ga conjugated to prostate-specific membrane antigen (PSMA)...
18 KB (1,306 words) - 16:47, 12 July 2024
the PSMA radioligand therapy (Pluvicto) requires the patient to have end-stage prostate cancer that has metastasized in other organs, the PSMA ligand...
35 KB (4,347 words) - 18:33, 11 August 2024
randomised phase 3 trial ("ProPSMA study") was published comparing Gallium-68 PSMA PET/CT to standard imaging (CT and bone scan). This 300 patient study conducted...
36 KB (4,325 words) - 18:37, 8 June 2024
It is the second PSMA-targeted PET imaging drug approved by the U.S. Food and Drug Administration (FDA). The first approved PSMA-targeted PET imaging...
11 KB (846 words) - 06:58, 31 December 2023
pulmonary indications. 177Lu-PSMA-617 and 68Ga-PSMA-617 are in development to treat, image, monitor and stage prostate cancer. PSMA-617 is a ligand of prostate-specific...
20 KB (1,764 words) - 09:43, 26 August 2024
nasopharynx overlying the torus tubarius. The tubarial salivary glands bind to PSMA, which is how they were discovered. The glands were discovered by a group...
3 KB (271 words) - 14:58, 14 November 2023
Emmett L, Willowson K, Violet J, Shin J, Blanksby A, Lee J (March 2017). "177 PSMA radionuclide therapy for men with prostate cancer: a review of the current...
13 KB (1,205 words) - 22:35, 3 December 2023
Flamen P (May 2017). "Vertebral Hemangioma Mimicking Bone Metastasis in 68Ga-PSMA Ligand PET/CT". Clinical Nuclear Medicine. 42 (5): 368–370. doi:10.1097/RLU...
15 KB (1,526 words) - 02:48, 12 June 2024
dosimetry estimates prior to 90Y immunotherapy for lymphoma 111In ProstaScint — PSMA antibody imaging of prostate cancer 111In pentetreotide (including in 111In...
5 KB (527 words) - 08:55, 2 May 2024
of gallium-68 on a biomedical cyclotron and automated radiolabelling of PSMA-11 and DOTATATE". EJNMMI Radiopharmacy and Chemistry. 6 (1): 1. doi:10...
16 KB (1,189 words) - 08:05, 2 July 2024
177Lu-PSMA or 225Ac-PSMA therapies. For local recurrence, 68Ga-PSMA PET/MR or PET/CT in combination with mpMR is most appropriate. PSMA PET/CT may be potentially...
47 KB (5,350 words) - 10:28, 6 August 2024
Yongxiang; Yin, Hongling; Hu, Shuo (2021). "18F-PSMA-1007 PET/CT uptake in multiple angiolipomas caused by PSMA expression in capillaries: a case report"....
12 KB (1,159 words) - 03:25, 24 August 2024
period to prepare the radiopharmaceutical and trace it, such as a fibrinogen scan to diagnose clotting. I-125's gamma radiation is of medium penetration, making...
20 KB (673 words) - 08:23, 17 January 2024
Excellence. 29 August 2018. Retrieved 3 September 2018. Kabasaka, Levent. "Lu-177-PSMA Real World Clinical Study: Out-patient or In-patient Treatment" (PDF). BNMS...
28 KB (2,914 words) - 02:17, 16 July 2024
diagnostics. Mirzaei and his team are the first center which is applying Cu-64 PSMA in prostate cancer. Somatostatin receptor scintigraphy (SRS) and therapy...
15 KB (1,942 words) - 16:45, 18 February 2023
Nitin; El-Haddad, Ghassan; Park, Chandler H. (June 23, 2021). "Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer". New England Journal...
30 KB (2,780 words) - 16:23, 26 December 2023
Leonardo Lima; Lemos, Gustavo Caserta (2020-02-24). "Kinetic modeling of 68Ga-PSMA-11 and validation of simplified methods for quantification in primary prostate...
17 KB (2,147 words) - 15:52, 17 September 2022
treatment. Results from Phase 2 trial recommended G-202 as a first-in-class PSMA-targeted prodrug and that it move to clinical trials. Current research includes...
90 KB (10,116 words) - 19:14, 14 August 2024
Positron-emitting and Fluorescent (HD-GPF) reporter system uses a human protein, PSMA and non-immunogenic, and a small molecule that is positron-emitting (boron...
47 KB (6,058 words) - 00:09, 19 May 2024
location intelligence tool, called GeoVision, which uses data provided by PSMA Australia and allows companies to "visualise, analyse, and ultimately make...
58 KB (5,254 words) - 00:18, 4 August 2024
resources. Since 2017, he steered the development of [68Ga]Ga-/[177Lu]Lu-PSMA-based theranostics and peptide receptor radioligand therapy (PRLT) in metastatic...
24 KB (2,616 words) - 00:59, 13 August 2023